Summary
9.34 0.83(9.75%)09/13/2024
American Well Corporation (AMWL)
American Well Corporation (AMWL)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 9.75 | 6.72 | 1.54 | 2,003.58 | 841.76 | 559.23 | 0.00 | -62.85 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 9.34 | |
| Open | 8.58 | |
| High | 9.51 | |
| Low | 8.55 | |
| Volume | 59,179 | |
| Change | 0.83 | |
| Change % | 9.75 | |
| Avg Volume (20 Days) | 43,552 | |
| Volume/Avg Volume (20 Days) Ratio | 1.36 | |
| 52 Week Range | 0.26 - 12.45 | |
| Price vs 52 Week High | -24.98% | |
| Price vs 52 Week Low | 3,492.31% | |
| Range | 5.02 | |
| Gap Up/Down | -0.11 | |
Fundamentals | ||
| Market Capitalization (Mln) | 128 | |
| EBIDTA | 0 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 10.43 | |
| Book Value | 4.9190 | |
| Earnings Per Share | -0.7210 | |
| EPS Estimate Current Quarter | -0.2400 | |
| EPS Estimate Next Quarter | -0.2500 | |
| EPS Estimate Current Year | -0.7900 | |
| EPS Estimate Next Year | -0.7100 | |
| Diluted EPS (TTM) | -0.7210 | |
| Revenues | ||
| Profit Marging | -0.7438 | |
| Operating Marging (TTM) | -0.7459 | |
| Return on asset (TTM) | -0.0774 | |
| Return on equity (TTM) | -0.1383 | |
| Revenue TTM | 240,471,008 | |
| Revenue per share TTM | 0.9700 | |
| Quarterly Revenue Growth (YOY) | -0.0050 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 88,475,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.2713 | |
| Revenue Enterprise Value | 3.5341 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 227,490,000 | |
| Shares Float | 202,375,530 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 18.80 | |
| Institutions (%) | 48.49 | |
08/22 16:05 EST - globenewswire.com
Amwell to Participate in Upcoming Investor Conferences
Boston, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in several investor conferences in September.
Amwell to Participate in Upcoming Investor Conferences
Boston, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in several investor conferences in September.
08/05 15:33 EST - investorplace.com
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Telemedicine stocks could do no wrong during the pandemic. With millions on lockdown and still in need of medical care, telemedicine stocks, like Teledoc Health (NYSE:TDOC) ranfrom about $80 to a high of $288.80.
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Telemedicine stocks could do no wrong during the pandemic. With millions on lockdown and still in need of medical care, telemedicine stocks, like Teledoc Health (NYSE:TDOC) ranfrom about $80 to a high of $288.80.
07/31 20:30 EST - zacks.com
American Well (AMWL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
American Well (AMWL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
07/31 20:04 EST - seekingalpha.com
American Well Corporation (AMWL) Q2 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbaugh - Morgan Stanley Jack Wallace - Guggenheim Securities Matthew Shea - Needham & Company Jenny Cao - Truist Securities Jessica Tassan - Piper Sandler David - from BTIG Charles Rhyee - TD Cowen Operator Good afternoon. My name is Rob, and I will be your conference operator today.
American Well Corporation (AMWL) Q2 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbaugh - Morgan Stanley Jack Wallace - Guggenheim Securities Matthew Shea - Needham & Company Jenny Cao - Truist Securities Jessica Tassan - Piper Sandler David - from BTIG Charles Rhyee - TD Cowen Operator Good afternoon. My name is Rob, and I will be your conference operator today.
07/31 20:02 EST - pymnts.com
Amwell Beats Q2 Expectations on Subscription Revenue Strength
Telehealth provider Amwell on Wednesday (July 31) reported second-quarter revenue of $62.8 million (above guidance of $61.1 million), driven by $27.5 million in subscription revenue and $28.7 million from visits to Amwell Medical Group (AMG). Despite a net loss of $49.9 million — down from $73.
Amwell Beats Q2 Expectations on Subscription Revenue Strength
Telehealth provider Amwell on Wednesday (July 31) reported second-quarter revenue of $62.8 million (above guidance of $61.1 million), driven by $27.5 million in subscription revenue and $28.7 million from visits to Amwell Medical Group (AMG). Despite a net loss of $49.9 million — down from $73.
07/31 19:26 EST - zacks.com
American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $3.36 per share versus the Zacks Consensus Estimate of a loss of $3.94. This compares to loss of $4.60 per share a year ago.
American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $3.36 per share versus the Zacks Consensus Estimate of a loss of $3.94. This compares to loss of $4.60 per share a year ago.
07/31 16:05 EST - globenewswire.com
Amwell Announces Results for Second Quarter 2024
Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the second quarter 2024 earnings report.
Amwell Announces Results for Second Quarter 2024
Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the second quarter 2024 earnings report.
07/24 11:07 EST - zacks.com
Will American Well Corporation (AMWL) Report Negative Earnings Next Week? What You Should Know
American Well (AMWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will American Well Corporation (AMWL) Report Negative Earnings Next Week? What You Should Know
American Well (AMWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
07/17 07:00 EST - globenewswire.com
Amwell® to Report Second Quarter 2024 Operating Results
Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31.
Amwell® to Report Second Quarter 2024 Operating Results
Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31.
06/28 07:00 EST - globenewswire.com
Amwell Announces Reverse Stock Split
Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company's Class A common stock are expected to begin trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis at the market open on July 11, 2024. No change will be made to the trading symbol for the Company's shares of Class A common stock, “AMWL”, in connection with the Reverse Split.
Amwell Announces Reverse Stock Split
Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company's Class A common stock are expected to begin trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis at the market open on July 11, 2024. No change will be made to the trading symbol for the Company's shares of Class A common stock, “AMWL”, in connection with the Reverse Split.
06/17 08:05 EST - globenewswire.com
Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors
Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13.
Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors
Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13.
06/13 08:05 EST - globenewswire.com
Amwell Co-Founder Roy Schoenberg Becomes Executive Vice Chairman of the Board
Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility
Amwell Co-Founder Roy Schoenberg Becomes Executive Vice Chairman of the Board
Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility
05/16 16:05 EST - globenewswire.com
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility
05/05 00:48 EST - seekingalpha.com
American Well Corporation (AMWL) Q1 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q1 2024 Earnings Call Transcript May 1, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Craig Hettenbach - Morgan Stanley Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Matthew Shea - Needham & Company Stan Berenshteyn - Wells Fargo Securities Hanna Lee - Bank of America Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Operator Good afternoon. My name is Briana, and I will be your conference operator today.
American Well Corporation (AMWL) Q1 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q1 2024 Earnings Call Transcript May 1, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Craig Hettenbach - Morgan Stanley Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Matthew Shea - Needham & Company Stan Berenshteyn - Wells Fargo Securities Hanna Lee - Bank of America Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Operator Good afternoon. My name is Briana, and I will be your conference operator today.
05/01 20:36 EST - zacks.com
Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
05/01 19:01 EST - zacks.com
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.24 per share a year ago.
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.24 per share a year ago.
04/17 07:00 EST - globenewswire.com
Amwell® to Report First Quarter 2024 Operating Results May 1
Boston, April 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1.
Amwell® to Report First Quarter 2024 Operating Results May 1
Boston, April 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1.
04/04 16:05 EST - globenewswire.com
Amwell Receives Continued Listing Standard Notice From NYSE
Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York Stock Exchange (NYSE) informing the company that it is not in compliance with the NYSE's continued listing minimum price criteria with respect to its Class A common stock because the average closing price of the company's Class A common stock was less than $1 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company's Class A common stock from the NYSE.
Amwell Receives Continued Listing Standard Notice From NYSE
Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York Stock Exchange (NYSE) informing the company that it is not in compliance with the NYSE's continued listing minimum price criteria with respect to its Class A common stock because the average closing price of the company's Class A common stock was less than $1 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company's Class A common stock from the NYSE.
03/06 06:00 EST - globenewswire.com
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
Amwell clients to present on automated care, Converge platform integration Amwell clients to present on automated care, Converge platform integration
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
Amwell clients to present on automated care, Converge platform integration Amwell clients to present on automated care, Converge platform integration
02/22 06:00 EST - globenewswire.com
Amwell Names Cynthia Horner, M.D., Chief Medical Officer
Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits
Amwell Names Cynthia Horner, M.D., Chief Medical Officer
Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits